NCT03176628View on ClinicalTrials.gov

Pharmacokinetics, Pharmacodynamics and Safety of Basis in Acute Kidney Injury Study

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

September 11, 2018

Study Completion Date

September 11, 2018

Conditions
Acute Kidney Injury
Interventions
DIETARY_SUPPLEMENT

Basis

NR is a form of vitamin B3; Pterostilbene is a natural dietary compound and the primary antioxidant component of blueberries

DIETARY_SUPPLEMENT

Placebo

Placebo capsule(s)

Trial Locations (1)

02118

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Elysium Health
All Listed Sponsors
collaborator

Elysium Health

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT03176628 - Pharmacokinetics, Pharmacodynamics and Safety of Basis in Acute Kidney Injury Study | Biotech Hunter | Biotech Hunter